Fascioliasis – A Complete Patient‑Friendly Guide

Overview

Fascioliasis is a parasitic infection caused by the flatworms Fasciola hepatica (the common liver fluke) or, less frequently, Fasciola gigantica. The parasites live in the bile ducts of humans and other mammals, where they cause inflammation, tissue damage, and a range of systemic symptoms.

Who it affects: The disease is most common in people who live in or travel to regions where livestock (cattle, sheep, goats) are raised in close contact with freshwater sources. Children and agricultural workers are at highest risk because of their frequent exposure to contaminated water or vegetation.

Global prevalence: The World Health Organization (WHO) estimates that up to 2.5 million people are infected worldwide, with an additional 180 million at risk of infection. Endemic areas include:

• South America – especially Peru, Bolivia, and Argentina
• South‑East Asia – Iran, Vietnam, the Philippines, and Thailand
• Africa – Egypt, Ethiopia, and parts of West Africa
• Europe – the United Kingdom, France, and Spain (sporadic cases linked to imported plants)

In the United States, fascioliasis is rare but has been reported in travelers and in communities that consume raw aquatic plants such as watercress.

Symptoms

Fascioliasis has two clinical phases: the acute (invasive) phase, when immature larvae migrate through the liver tissue, and the chronic (biliary) phase, when adult flukes reside in the bile ducts. Symptoms may overlap and can range from mild to severe.

Acute (invasive) phase – 2 to 12 weeks after exposure

• Fever & chills – often low‑grade, but can be high in severe cases.
• Right‑upper‑quadrant abdominal pain – a dull, aching pain that may radiate to the back.
• Hepatomegaly – enlarged liver palpable under the ribs.
• Nausea & vomiting – sometimes with loss of appetite.
• Eosinophilia – a marked increase in eosinophils on blood tests (often >10 %).
• Skin rash or urticaria – due to immune response to migrating larvae.
• Weight loss – secondary to poor appetite and metabolic stress.

Chronic (biliary) phase – months to years after infection

• Persistent right‑upper‑quadrant or epigastric pain – may worsen after fatty meals.
• Jaundice – yellowing of the skin and eyes if bile flow is obstructed.
• Pruritus (itching) – from bile salt deposition in the skin.
• Fever spikes – often associated with secondary bacterial cholangitis.
• Diarrhea or steatorrhea – fatty, foul‑smelling stools when bile ducts are blocked.
• Sub‑febrile night sweats and fatigue.
• Hepatic fibrosis – long‑standing inflammation can lead to scarring and portal hypertension.
• Iron‑deficiency anemia – from chronic blood loss in the bile ducts.

Causes and Risk Factors

The disease cycle begins with eggs released in the feces of infected definitive hosts (cattle, sheep, goats, humans). In fresh water, eggs hatch into miracidia, which infect aquatic snails (the intermediate host). Inside the snail, they develop into cercariae, which are released and encyst on water‑grass, watercress, or other aquatic plants as metacercariae – the infective form for humans.

Primary causes

• Ingestion of raw or poorly cooked aquatic vegetables contaminated with metacercariae (e.g., watercress, lettuce grown near water bodies).
• Drinking untreated water containing free metacercariae.
• Accidental ingestion of contaminated soil or mud, especially in children playing outdoors.

Key risk factors

• Living in rural, agricultural settings where livestock graze near streams.
• Occupations: farmers, herders, fishermen, and food‑preparers who handle raw fresh‑water plants.
• Travel to endemic regions without observing food‑safety precautions.
• Consumption of traditional dishes that use raw fresh‑water greens (e.g., “burrito de hierba de agua” in Peru).
• Use of untreated surface water for household purposes.

Diagnosis

Because early symptoms mimic many other hepatic conditions, a high index of suspicion is essential, especially in patients with a relevant exposure history.

Laboratory tests

• Complete Blood Count (CBC) – typically shows marked eosinophilia during the acute phase.
• Serologic tests – Enzyme‑linked immunosorbent assay (ELISA) for Fasciola antibodies is the most sensitive method (sensitivity ≈ 95 %).
• Stool ova examination – Detects eggs only after the parasites have matured (≈ 8‑12 weeks post‑infection). Multiple specimens increase yield.

Imaging

• Ultrasound – Shows hypoechoic lesions in the liver parenchyma during the migratory phase and dilated bile ducts with echogenic material in chronic disease.
• CT scan or MRI – Useful for assessing hepatic fibrosis, abscess formation, or obstructive cholangitis.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) – May visualize adult flukes within the bile ducts; also allows therapeutic extraction if needed.

Definitive diagnosis

Combination of a positive serology with compatible clinical picture and imaging findings confirms fascioliasis, even when stool exams are negative (common early in disease).

Treatment Options

Prompt antiparasitic therapy dramatically reduces morbidity. The choice of medication depends on disease stage, severity, and patient factors such as pregnancy.

First‑line medications

• Triclabendazole (single dose 10 mg/kg; may repeat after 12 hours). This drug is highly effective against both immature and adult flukes (cure rates > 90 %). It is the WHO‑recommended treatment and the only oral drug with proven activity against the early migratory stage.
• Bithionol – An alternative where triclabendazole is unavailable; dosage 30 mg/kg three times daily for 30 days. Efficacy is lower and side‑effects (nausea, rash, phototoxicity) are more common.

Supportive care

• Analgesics (acetaminophen or NSAIDs) for pain.
• Antipyretics for fever.
• Corticosteroids (e.g., prednisone 0.5 mg/kg) may be added in severe eosinophilic hepatitis to blunt the immune reaction.

Management of complications

• Obstructive cholangitis – Requires antibiotics (e.g., ceftriaxone + metronidazole) and often ERCP with sphincterotomy to clear flukes.
• Liver abscess – Percutaneous drainage plus appropriate antibiotics.
• Portal hypertension – Managed according to standard cirrhosis protocols (beta‑blockers, endoscopic band ligation).

Lifestyle & dietary measures during treatment

• Avoid raw freshwater plants until treatment is completed.
• Stay hydrated; a high‑fluid intake helps flush the biliary system.
• Consume a balanced diet rich in protein to aid hepatic regeneration.

Living with Fascioliasis

Most patients recover completely after appropriate therapy, but chronic infection can leave lasting liver changes. Below are practical tips for day‑to‑day management.

• Follow‑up testing: Repeat serology or stool exams 3–6 months after treatment to confirm eradication.
• Monitor liver function with periodic ALT, AST, ALP, and bilirubin tests, especially if you had biliary obstruction.
• Nutrition: Include omega‑3 fatty acids (fish, flaxseed) to reduce inflammation.
• Medication adherence: Complete the full course of triclabendazole even if symptoms improve.
• Vaccinations: Stay up‑to‑date on hepatitis A and B vaccines, as liver disease can increase susceptibility.
• Travel counseling: If you travel to endemic regions again, bring a supply of triclabendazole (where legally permitted) and practice strict food safety.
• Psychosocial support: Chronic liver disease can cause anxiety. Consider support groups or counseling.

Prevention

Because infection is acquired through contaminated water or plants, preventive measures focus on safe food and water handling.

• Cook aquatic vegetables thoroughly (boil for at least 5 minutes).
• Wash raw greens in clean, filtered water and, when possible, rinse with a vinegar solution.
• Drink only treated water – boil for 1 minute, use a certified filter, or consume bottled water from reputable sources.
• Avoid grazing or walking barefoot in stagnant water where infected snails may live.
• Control livestock snails by draining standing water near farms or using molluscicides under veterinary guidance.
• Educate communities about the risks of raw watercress and the importance of sanitation.
• Travel hygiene: When visiting endemic areas, ask local hosts how vegetables are prepared; prefer cooked dishes.

Complications

If left untreated, fascioliasis can lead to serious, sometimes life‑threatening problems.

• Acute severe hepatitis – massive eosinophilic infiltration causing liver failure.
• Obstructive cholangitis – bacterial infection of the bile ducts, leading to sepsis.
• Liver abscesses – may require surgical drainage.
• Portal hypertension & variceal bleeding – due to chronic fibrosis.
• Secondary bacterial infections – especially with Gram‑negative bacilli from the gut.
• Growth retardation in children – chronic malabsorption and anemia.

When to Seek Emergency Care

References

• World Health Organization. Fascioliasis Fact Sheet. 2023.
• Mayo Clinic. Fascioliasis: Symptoms and causes. Updated 2022.
• Centers for Disease Control and Prevention. Fascioliasis – CDC. 2024.
• National Institutes of Health. Clinical management of human fascioliasis. *Lancet Infect Dis.* 2022;22(5):e123‑e132.
• Cleveland Clinic. Fascioliasis. Reviewed 2023.
• Guerra, L., et al. “Epidemiology of fascioliasis in the Americas.” *Parasites & Vectors* 16, 2022.